Project Grant HT94252310757
Award Date 8/15/23
Completion Date 2/14/26
Dollars Obligated $553K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
La Jolla, CA 92093, USA
Similar Awards
- The University of California, San Diego (UC San Diego) was awarded a $592,500 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on February 1, 2025, supports the development of a "Mutant DNA-Activated Killing System for Precision Breast Cancer Therapy". The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical...
- The University of California, San Diego (UCSD) was awarded a $592,500.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop a "Mutant DNA-Activated Killing System for Precision Breast Cancer Therapy." The award, which spans from February 1, 2025 to January 31, 2028, aims to support advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. UCSD, a...
- The University of California, San Diego (UCSD) was awarded a $551,207.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to research a new therapeutic target to prevent pancreatic cancer metastasis. The 3-year grant period runs from July 1, 2023 to June 30, 2026. The project aims to investigate medical solutions for the battlefield by transforming health care through innovative and impactful research in areas like cancer...
- The University of California, San Diego (UCSD) was awarded a $789,987.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on August 1, 2023 with a completion date of July 31, 2026, will support research on CTL-tolerant melanoma persister cells. The research aims to transform health care for Service Members and the American public through innovative and impactful research, and to investigate...
- The University of California, San Diego (UCSD) was awarded a $1,184,999 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support UCSD's project "QUANTITATIVE ADVANCED DIFFUSION MRI FOR RELIABLE DETECTION AND ENHANCED TREATMENT OF HIGH-GRADE PROSTATE CANCER" from July 1, 2023 to June 30, 2027. Through this funding, UCSD will conduct research to advance the detection and treatment of high-grade prostate...
- The University of California, San Diego (UCSD), doing business as UC San Diego Health, was awarded a $1,580,000 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420). The grant, awarded on March 1, 2025, will support a research project titled "Multiomic Approaches for Noninvasive Prediction of Inflammatory Bowel Disease Exacerbations." The project aims to develop innovative biomedical solutions to address critical health...
- The University of California, San Diego (UCSD) has been awarded a $593,241 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund research to identify a new therapeutic target to prevent metastasis in pancreatic cancer. The three-year project, running from July 1, 2023 to June 30, 2026, leverages UCSD's expertise in cognitive science, computer science, and neuroscience to advance artificial intelligence...
- Federal Grant Award Summary The University of California, San Diego (UC San Diego) received a $1,197,884 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded on August 15, 2025, with a completion date of August 14, 2028. The award funds research focused on mechanism dissection and model development of human PD1 (Programmed Death Receptor 1) in melanoma, a critical cancer immunotherapy research initiative relevant to...
- This $802,068 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by the University of California, San Diego (UCSD) to investigate how sublethal apoptotic signaling promotes melanoma adaptation to immune attack. The research aims to transform health care for service members and the broader public through innovative and impactful biomedical studies. The grant provides funding for UCSD's...
- The Defense Health Agency awarded a $1,453,500.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, commencing on June 20, 2023, will support UCSF's research to profile and eliminate tumor subclones resistant to radioligand therapy. Through this project, UCSF aims to transform health care for Service Members and the American public by developing innovative and...